The differential effectiveness of HCN isoforms for biopacemaking as a potential therapy for sick sinus syndrome.

Research output: Contribution to journal › Commentary/debate › peer-review

Cite this

@article{13977ef5cb93447d8a9a84f76af85ab4,

title = "The differential effectiveness of HCN isoforms for biopacemaking as a potential therapy for sick sinus syndrome.",

author = "GM Morris and PA Kingston and H Dobrzynski and M Lei and RB Robinson and MR. Boyett",

year = "2011",

month = aug,

language = "English",

volume = "32",

pages = "997",

journal = "European Heart Journal",

issn = "1522-9645",

publisher = "Oxford University Press",

number = "Suppl 1",

}

TY - JOUR

T1 - The differential effectiveness of HCN isoforms for biopacemaking as a potential therapy for sick sinus syndrome.

AU - Morris, GM

AU - Kingston, PA

AU - Dobrzynski, H

AU - Lei, M

AU - Robinson, RB

AU - Boyett, MR.

PY - 2011/8

Y1 - 2011/8

M3 - Commentary/debate

SN - 1522-9645

VL - 32

SP - 997

JO - European Heart Journal

JF - European Heart Journal

IS - Suppl 1

ER -